ImmusanT, Inc.   Report issue

For profit Phase 2
Founded: Cambridge MA United States (2011)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2013
NCT01932476
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

ImmusanT, Inc.